Cervical Er:YAG Laser in Low-Risk CIN Management: A Promising Option Compared to Expectant Management and Conservative Treatments — A Pilot Study
This pilot study demonstrates that cervical Er:YAG laser treatment yields superior colposcopic regression and HPV clearance rates compared to silicon dioxide-based vaginal gel in managing low-risk cervical dysplasia, while also offering a more immediate resolution than expectant management despite a small risk of progression in the latter group.